0       0

29th Annual North American Cystic Fibrosis Conference


W14: NT: Early Studies of Novel Small Molecule Therapies


Oct 9, 2015 2:00pm ‐ Oct 9, 2015 3:45pm

Standard: $49.99

Description

This session will consider novel small molecule therapeutic approaches directed at CF relevant drug targets, including delF508-CFTR, epithelial sodium channels & less frequent CFTR mutations. The session provides perspectives from academic & industrial laboratories.

Educational Objectives:

  1. Discuss innovative approaches to restore the expression, stability & function of delF508-CFTR.
  2. Review the challenges of developing rational new therapies for rare CF mutations.
  3. Explain the therapeutic potential for CF lung disease of small molecules that modify ENaC function.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content